Companies implementing Health Economics Outcomes Research (HEOR)
HEOR blends economic and outcomes analyses with traditional clinical data—such as efficacy, safety, and quality—to assist decision‑makers in determining patient access to drugs and services.
1,925
companies
List of companies that implement Health Economics Outcomes Research (HEOR)
| Company | Country | Industry | Employees | Revenue | Technologies |
|---|---|---|---|---|---|
United States | Biotechnology Research | 6.2k | $7.6B | Health Economics Outcomes Research (HEOR) | |
United States | Pharmaceutical Manufacturing | 39k | $46B | Health Economics Outcomes Research (HEOR) | |
United States | Pharmaceutical Manufacturing | 62k | $26B | Health Economics Outcomes Research (HEOR) | |
Switzerland | Pharmaceutical Manufacturing | 102k | $51B | Health Economics Outcomes Research (HEOR) | |
France | Pharmaceutical Manufacturing | 92k | $46B | Health Economics Outcomes Research (HEOR) | |
Switzerland | Research Services | 130k | $44B | Health Economics Outcomes Research (HEOR) | |
United States | Hospitals and Health Care | 81k | $14B | Health Economics Outcomes Research (HEOR) | |
Germany | Pharmaceutical Manufacturing | 53k | $26B | Health Economics Outcomes Research (HEOR) | |
United Kingdom | Pharmaceutical Manufacturing | 79k | Health Economics Outcomes Research (HEOR) | ||
United States | Pharmaceutical Manufacturing | 103k | $100B | Health Economics Outcomes Research (HEOR) |
Showing top companies out of 1,925 that implement Health Economics Outcomes Research (HEOR). Get the full list on TheirStack.
Frequently asked questions









